by Stacey Johnson | Jan 5, 2024
If you only read one post for 2023, please make it this one. Below are the 10 most popular posts from last year, as determined by views recorded on the website. These are not my favourite posts, although I like all of them; this ranking is completely unbiased and...
by Stacey Johnson | Dec 29, 2023
It’s been a busy year in the cell and gene therapy community and the bloggers at Signals have enjoyed putting the spotlight on news (HeLa settlement and UK rejoins Horizon Europe), scientific advances (improving treatment for hematological malignancies and a new...
by Stacey Johnson | May 7, 2021
The incredible, non-stop growth of the global cell and gene therapy market – valued at ~$12 billion by 2025 – means that talent is in high demand. (That estimate does not include tissue engineering, but it still seems low.) While seasoned professionals and those with...
by Nicole Kuchinsky | Feb 24, 2021
I spent over a decade (12.5 years to be exact) getting university degrees in life sciences. Let’s also not forget the 4.5 years I spent as a post-doctoral fellow. All told, I have 17 years of experience as an academic trainee. When I finally decided to make the jump...
Comments